The company voluntarily recalled all of its products from this site in August 2021.
This is the first approval for a generic version of Spiriva HandiHaler in the U.S.
Over the course of two sessions, the stock has gained approximately 12%, with a significant 7% increase observed on June 20 after a large deal.
The objective of this partnership is to tackle the increasing occurrence of Cardiovascular Diseases (CVD) and Chronic Obstructive Pulmonary Disease (COPD) in the Palghar district of Maharashtra.
Taiho Oncology Inc. sells Lonsurf in the United States.
The study will continue for approximately 56 weeks.
The company will manufacture the product at the group’s formulation facility located in Moraiya, Ahmedabad (India).
This is the 27th international GMP approval for Venus Remedies.
FPP Holding serves as the parent company for Florida Pharmaceutical Products, LLC (FPP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
